Marshall Wace North America’s HealthStream HSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-13,814
Closed -$305K 1321
2020
Q2
$305K Buy
+13,814
New +$320K ﹤0.01% 1006
2020
Q1
Sell
-3,136
Closed -$85K 1394
2019
Q4
$85K Sell
3,136
-7,847
-71% -$216K ﹤0.01% 1076
2019
Q3
$284K Buy
+10,983
New +$295K ﹤0.01% 899
2018
Q3
Sell
-88,309
Closed -$2.41M 1110
2018
Q2
$2.41M Buy
88,309
+77,915
+750% +$2.07M 0.01% 719
2018
Q1
$258K Buy
10,394
+105
+1% +$2.52K ﹤0.01% 1289
2017
Q4
$238K Sell
10,289
-140,888
-93% -$3.32M ﹤0.01% 1262
2017
Q3
$3.48M Buy
+151,177
New +$3.59M 0.02% 648

Other funds holding HSTM

Marshall Wace North America's HSTM Position: Q3 2020 in Review

Marshall Wace North America sold out of HealthStream (HSTM) in Q3 2020, closing a stake of 13,814 shares — an estimated $305K sold.

Marshall Wace North America first reported a position in HSTM in Q3 2017 and held it in 7 quarters. The position peaked at $3.48M in Q3 2017. 162 funds tracked by Wall St. Rank hold HSTM as of Q3 2020.

  • Marshall Wace North America reported no remaining HealthStream position as of Q3 2020 after selling out during the quarter.
  • Marshall Wace North America sold 13,814 HealthStream shares in Q3 2020, an estimated $305K.
  • Marshall Wace North America first reported a position in HealthStream in Q3 2017 and held it in 7 quarters.
  • Marshall Wace North America's HealthStream position peaked at $3.48M in Q3 2017.
  • 162 funds tracked by Wall St. Rank held HealthStream as of Q3 2020.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.